Stanford Cancer Institute - School of Medicine — Palo Alto, California

Stanford Cancer Institute - School of Medicine is a clinical research site located in Palo Alto, California, United States 94394.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute - School of Medicine has participated in 1 clinical trials.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute - School of Medicine?

Stanford Cancer Institute - School of Medicine has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute - School of Medicine conducted?

Stanford Cancer Institute - School of Medicine has 1 clinical trials on record. Their work covers Urothelial Carcinoma.

Is Stanford Cancer Institute - School of Medicine accredited by Crixeo Clinical Trials?

Stanford Cancer Institute - School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute - School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.